Conjugation, immunoreactivity, and immunogenicity of calix[4]arenes; model study to potential calix[4]arene-based Ac3+ chelators

Bioconjugate Chemistry

Volumn 10, Issue 4, 1999, Pages 613-623

  Grote Gansey, Marcel H B ^a   De Haan, Annemarie S ^b   Bos, Ebo S ^b   Verboom, Willem ^a   Reinhoudt, David N ^a  

^a UNIVERSITY OF TWENTE   (Netherlands)

^b NV ORGANON   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC COMPOUNDS; BIOMOLECULES; CHELATION; IMMUNE SYSTEM; MAMMALS;

CALIXARENES; CALIX[4]ARENE CARBOXYLIC ACIDS; CALIX[4]ARENES; CHARACTERIZATION TECHNIQUES; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOREACTIVITIES; ISOTHIOCYANATES; MODELLING STUDIES; SERUM ALBUMIN;

MONOCLONAL ANTIBODIES;

ANIMALIA; ARENE;

EID: 0001590259     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc9801474     Document Type: Article

References (34)

1. Parker, D. (1990) Tumour targeting with radiolabeled macrocycle-antibody conjugates. Chem. Soc. Rev. 19, 271.
2. Goldenberg, D. M. (1991) Cancer imaging and therapy with radiolabeled antibodies. Immunobiol. Proteins Pept. VI, 107.
3. Yuanfang, L., and Chuanchu, W. (1991) Radiolabeling of monoclonal antibodies with metal chelates. Pure Appl. Chem. 63, 427.
4. Parker, D. (1990) Tumor targeting. Chem. Brit. 942.
5. Suey, C. M., DeNardo, G. L., DeNardo, S. J., and Gobuty, A. H. (1990) Radioimmunotherapy with monoclonal antibodies. J. Nucl. Med. Technol. 18, 176.
6. Meares, C. F., Diril, H., Kukis, D., McCall, M., Rana, T., Wellman, A., DeNardo, S. J., and DeNardo, G. L. (1991) Radiochemistry of antibodies: some recent advances. Antibody, Immunoconj. Radiopharm. 4, 389.
7. Epperly, M. W., and Bloomer, W. D. (1991) Radiotherapy: the closer the better. Chemtech 744.
8. Böhmer, V. (1995) Calixarenes, macrocycles with (almost) unlimited possibilities. Angew. Chem., Int. Ed. Engl. 34, 713, and references cited therein.
9. Ikeda, A., and Shinkai, S. (1997) Novel cavity design using calix[n]arenes skeletons: toward molecular recognition and metal binding. Chem. Rev. 97, 1713, and references therein.
10. Grote Gansey, M. H. B., Steemers, F. J., Verboom, W., and Reinhoudt, D. N. (1997) Synthesis of neutral, water-soluble calix[4]arenes. Synthesis 643.
11. Steemers, F. J., Meuris, H. G., Verboom, W., Reinhoudt, D. N., Van der Tol, E. B., and Verhoeven, J. W. (1997) Water-soluble neutral calix[4]arene-lanthanide complexes. J. Org. Chem. 62, 4229.
12. Steemers, F. J., Verboom, W., Reinhoudt, D. N., Van der Tol, E. B., and Verhoeven, J. W. (1995) New sensitizer-modified calix[4]arenes enabling near-UV excitation of complexed luminescent lanthanide ions. J. Am. Chem. Soc. 117, 9408.
13. Iwema Bakker, W. I., Haas, M., Den Hertog, H. J., Jr., Verboom, W., De Zeeuw, D., Bruins, A. P., and Reinhoudt, D. N. (1994) Functionalized calixspherands: synthesis and peptide coupling. J. Org. Chem. 59, 972.
14. Iwema Bakker, W. I., Haas, M., Khoo-Beattie, C., Ostaszewski, R., Franken, S. M., Den Hertog, H. J., Jr., Verboom, W., De Zeeuw, D., Harkema, S., and Reinhoudt, D. N. (1994) Kinetically stable complexes of alkali cations with calixspherands: an evaluation of shielding. J. Am. Chem. Soc. 116, 123.
15. 3+, see Grote Gansey, M. H. B., Verboom, W., Van Veggel, F. C. J. M., Vetrogon, V., Arnaud-Neu, F., Schwing-Weill, M.-J., and Reinhoudt, D. N. (1998) Model studies toward trivalent cation binding by appropriately functionalized calix[4]arenes. J. Chem. Soc., Perkin Trans. 2, 2351.
16. 225Ac as a source of α-particles in radioimmunotherapy. Nucl. Med. Commun. 14, 121.
17. 225Ac-immunoconjugates. Nucl. Med. Commun. 16, 468.
18. Chen, X., Ji, M., Fisher, D. R., and Wai, C. M. (1998) Carboxylate-derived calixarenes with high selectivity for actinium-225. Chem. Commun. 377.
19. Kosmas, C., Snook, D., Gooden, C. S., Courtenay-Luck, N. S., McCall, M. J., Meares, C. F., and Epenetos, A. A. (1992) Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy. Cancer Res. 52, 904.
20. Kosmas, C., Maraveyas, A., Gooden, C. S., Snook, D., and Epenetos, A. A. (1995) Anti-chelate antibodies after intraperitoneal yttrium-90-labeled monoclonal antibody immunoconjugates for ovarian cancer therapy. J. Nucl. Med. 36, 746.
21. McKervey, M. A., Seward, E. M., Ferguson, G., Ruhl, B., and Harris, S. J. (1985) Synthesis, X-ray crystal structures, and cation transfer properties of alkyl calixaryl acetates, a new series of molecular receptors. J. Chem. Soc., Chem. Commun. 388.
22. Pham, D. T., Kaspersen, F. M., and Bos, E. S. (1995) Electrophoretic method for the quantitative determination of a benzyl-DTPA ligand in DTPA monoclonal antibody conjugates. Bioconjugate Chem. 6, 313.
23. Hoes, C. J. T., Grootoonk, J., Feijen, J., Boon, P. J., Kaspersen, F. M., Loeffen, P., Schlachter, I., Winters, M., and Bos, E. S. (1992) Synthesis and biodistribution of immunoconjugates of a human IgM and polymeric drug carriers. J. Controlled Release 19, 59.
24. Westerberg, D. A., Carney, P. L., Rogers, P. E., Kline, S. J., and Johnson, D. K. (1989) Synthesis of novel bifunctional chelators and their use in preparing monoclonal antibody conjugates for tumor targeting. J. Med. Chem. 32, 236.
25. Izard, M. E., Boniface, G. R., Hardiman, K. L., Brechbiel, M. W., Gansow, O. A., and Walker, K. Z. (1992) An improved method for labeling monoclonal antibodies with samarium-153: use of the bifunctional chelate 2-(p-isothiocyanatobenzyl)-6-methyldiethylenetriaminepentaacetic acid. Bioconjugate Chem. 3, 346.
26. 111indium-DOTA chelates: a simple and efficient method. Bioconjugate Chem. 5, 101.
27. 3+ complexes. J. Chem. Soc., Perkin Trans. 2 131.
28. + ion: evidence for hydronium ion complexation. J. Chem. Soc., Perkin Trans, 1 431.
29. Drobnica, L., Kristián, P., and Augustín, J. (1977) The Chemistry of the -NCS group; The Chemistry of Cyanates and Their Thio Derivatives; The Chemistry of Functional Groups, John Wiley & Sons: Chichester.
30. Ebright, Y. W., Chen, Y., Pendergrast, P. S., and Ebright, R. H. (1992) Incorporation of an EDTA-metal complex at a rationally selected site within a protein: application to EDTA-iron DNA affinity cleaving with catabolite gene activator protein (CAP) and Cro. Biochemistry 31, 10664.
31. Roitt, I. M., Brostoff, J., and Male, D. K. (1989) Immunology, 2nd ed., Gower Medical Publishing: London.
32. Carlsson, J., Drevin, H., and Axen, R. (1978) Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent. Biochem. J. 173, 723.
33. Schubiger, P. A., Alberto, R., and Smith, A. (1996) Vehicles, chelators, and radionuclides: choosing the "building blocks" of an effective therapeutic radioimmunoconjugate. Bioconjugate Chem. 7, 165.
34. DeNardo, S. J., Richman, C. M., Goldstein, D. S., Shen, S., Salako, Q., Kukis, D. L., Meares, C. F., Yuan, A., Welborn, J. L., and Denardo, G. L. (1997) Yttrium-90/indium-111-DOTA-peptide-chimeric L6: Pharmacokinetics, dosimetry and initial results in patients with incurable breast cancer. Anticancer Res. 17, 1735.